AZD3759

Min.Order / FOB Price:Get Latest Price

1 Gram	Negotiable

1 Gram

Negotiable

Min.Order :1 Gram
Purity: 98%min
Payment Terms : L/C,T/T

Keywords

AZD3759 1626387-80-1 tinib

Quick Details

Appearance:
Application:AZD3759 is a potent, oral active, central nervous system-penetrant, EGFR inhibitor. At Km ATP concentrations, the IC50 values were 0.3, 0.2, and 0.2 nM for EGFR TK wild-type, L858R mutant, and Exon 19
PackAge:
ProductionCapacity:10|Kilogram|Month
Storage:2-8℃
Transportation:

Superiority:

1. manufacturing at GMP factory.

2. high purity and very low single impurity.

3.very competitive price.

Details:

AZD3759 is a potent, oral active, central nervous system-penetrant, EGFR inhibitor. At Km ATP concentrations, the IC50 values were 0.3, 0.2, and 0.2 nM for EGFR TK wild-type, L858R mutant, and Exon 19Del enzymes, respectively.
IC50 value: 7.2 nM (L858R pEGFR)
Target: EGFR
in vitro: The inhibition of AZD3759 against EGFR tyrosine kinase (EGFR TK) wild type and mutant enzymes was tested at their corresponding Km and 2mM ATP concentrations. AZD3759 demonstrated inhibitory effects on both the pEGFR pathway and cell proliferation of EGFR mutation-derived cells PC-9 and H3255. AZD3759 was selected as the candidate for comprehensive biological profiling.
in vivo: AZD3759 exhibits the best pharmacokinetic profile with moderate blood clearance at 17 mL/min/kg and volume of distribution of 5.2 L/kg. The intrinsic clearance (Clint) of AZD3759 is 11.4 μL/min 106 cells in human hepatocytes, and the predicted clearance of the agent in humans is 7.7 mL/min/kg by extrapolation (IVIVe).